Načítá se...

Inhibition of human immunodeficiency virus type-1 by cdk inhibitors

Current therapy for human immunodeficiency virus (HIV-1) infection relies primarily on the administration of anti-retroviral nucleoside analogues, either alone or in combination with HIV-protease inhibitors. Although these drugs have a clinical benefit, continuous therapy with the drugs leads to dru...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Guendel, Irene, Agbottah, Emmanuel T, Kehn-Hall, Kylene, Kashanchi, Fatah
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2010
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2852372/
https://ncbi.nlm.nih.gov/pubmed/20334651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-6405-7-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!